[Thrombosis and cancer. An update of our knowledge].
D000818:Animals; D000925:Anticoagulants / Q000009:adverse effects / Q000627:therapeutic use*; D001777:Blood Coagulation / Q000187:drug effects; D017984:Enoxaparin / Q000627:therapeutic use; D005343:Fibrinolytic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D006470:Hemorrhage / Q000139:chemically induced; D006801:Humans; D009369:Neoplasms / Q000097:blood* / Q000150:complications*; D013923:Thromboembolism / Q000097:blood / Q000209:etiology; D013927:Thrombosis / Q000097:blood* / Q000188:drug therapy / Q000209:etiology* / Q000517:prevention & control; D020246:Venous Thrombosis / Q000097:blood / Q000209:etiology
D000925:Anticoagulants; D017984:Enoxaparin; D005343:Fibrinolytic Agents